Gf Fund Management Co. Ltd. Kymera Therapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,658 shares of KYMR stock, worth $48,894. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,658
Previous 1,360
21.91%
Holding current value
$48,894
Previous $54.7 Million
17.06%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding KYMR
# of Institutions
182Shares Held
67.4MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$198 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$191 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$177 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$177 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$154 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.61B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...